Eric Guglielmo, MD
Retina Specialist · Merritt Island, FLNPI 1093866840
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $468 of the $655 with a category attached, or 71.4%. 9 manufacturers reported payments, led by US Retina LLC at 28.6% of the total. That places this record below the midpoint for retina specialist clinicians in FL, where the typical reported total is $2,986.
Across 18 payments — averaging $36.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$188
- Regeneron Healthcare Solutions, Inc.$139
- AbbVie$76
- Genentech USA, Inc.$57
- Astellas Pharma US Inc$55
- ANI Pharmaceuticals, Inc.$48
- plus $94 from 3 others
Across 4 payments — averaging $368,686 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$1.5M
What the payments were for
- Food & beverage$46871%
- Ownership interest$18829%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 2 | $188 |
| Regeneron Healthcare Solutions, Inc. | 3 | $139 |
| AbbVie(2 entities) | 3 | $76 |
| Genentech USA, Inc. | 2 | $57 |
| Astellas Pharma US Inc | 2 | $55 |
| ANI Pharmaceuticals, Inc. | 2 | $48 |
| Apellis Pharmaceuticals, Inc. | 2 | $45 |
| Sandoz | 1 | $29 |
| Eyepoint US, Inc. | 1 | $20 |
How this compares
$655 in reported general payments places this provider in the 20th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 34 | $1,114 |
| Ofloxacin | 11 | $128 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Merritt Island
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Eduardo UchiyamaFt Lauderdale$356K
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Philip RosenfeldMiami$206K
- John MyersPensacola$152K
- Timothy MurraySouth Miami$133K
- Adiel SmithAventura$116K
- Paul GalloglyPalm Beach Gardens$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.